Lisinopril And Hydrochlorothiazide
Product Images NDC 53002-1308

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 53002-1308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Lisinopril (Image 1)

Chemical structure diagram of the active ingredient Lisinopril, showing its molecular framework including phenyl and pyrrolidine rings, with associated functional groups and a water of hydration (2H2O).*

FDA Label Image

Structural Formula Of Hydrochlorothiazide (Image 2)

Chemical structure diagram of the active ingredient related to Lisinopril and Hydrochlorothiazide by RPK Pharmaceuticals, Inc., showing molecular bonds and atom groups including sulfur, chlorine, nitrogen, and oxygen within a ring structure.*

FDA Label Image

Label Image (Lbl530021308)

Packaging label for Lisinopril and Hydrochlorothiazide tablets, 10-12.5 mg strength, manufactured by RPK Pharmaceuticals, Inc. The label indicates a bottle of 100 round tablets with instructions to take one tablet daily or as directed, with space for patient and prescriber information. The label includes lot number and expiration date details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.